NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 3 filers reported holding NOVOCURE LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $592,115 | -45.9% | 36,215 | +38.1% | 0.00% | 0.0% |
Q2 2023 | $1,093,654 | -31.5% | 26,233 | -1.1% | 0.00% | -50.0% |
Q1 2023 | $1,595,815 | +410.0% | 26,535 | +506.0% | 0.00% | – |
Q4 2022 | $312,920 | -78.1% | 4,379 | -76.2% | 0.00% | -100.0% |
Q3 2022 | $1,432,000 | +30.4% | 18,392 | +18.1% | 0.00% | 0.0% |
Q2 2022 | $1,098,000 | -18.2% | 15,567 | +157.5% | 0.00% | +100.0% |
Q2 2021 | $1,342,000 | +287.9% | 6,046 | +132.3% | 0.00% | – |
Q1 2021 | $346,000 | -46.9% | 2,603 | -30.8% | 0.00% | -100.0% |
Q4 2020 | $651,000 | +110.7% | 3,763 | +36.9% | 0.00% | – |
Q3 2020 | $309,000 | -35.2% | 2,748 | -63.6% | 0.00% | -100.0% |
Q2 2019 | $477,000 | +97.9% | 7,551 | +51.0% | 0.00% | – |
Q1 2019 | $241,000 | – | 5,002 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |